- Report
- May 2024
- 160 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- July 2024
- 185 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- May 2024
- 174 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2025
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- June 2024
- 200 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- May 2024
- 70 Pages
United States
From €4505EUR$4,950USD£3,827GBP
- Report
- September 2021
- 150 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- April 2025
Global
From €300EUR$353USD£264GBP
- Report
- November 2021
- 222 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Report
- October 2023
- 85 Pages
United States
From €4414EUR$4,850USD£3,749GBP
- Report
- May 2022
- 196 Pages
Global
From €2389EUR$2,625USD£2,029GBP
€4778EUR$5,250USD£4,059GBP
- Report
- August 2023
- 250 Pages
Global
From €2266EUR$2,490USD£1,925GBP
- Report
- October 2022
- 270 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- September 2022
- 232 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- August 2022
- 222 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- May 2022
- 190 Pages
Global
From €3186EUR$3,500USD£2,706GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more